ASH 2009 meeting report - Top 10 clinically oriented abstracts in acute leukemia

Amber Fullmer, Jorge Cortes, Hagop Kantarjian, Elias Jabbour

Research output: Contribution to journalArticle


The 2009 American Society of Hematology (ASH) annual meeting introduced novel strategies for the treatment of acute leukemia. Targeted inhibitors for both acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) represent the future of these malignancies. Inclusion of targeted treatment to combination chemotherapy may translate into improved cure rates. The most clinically relevant abstracts, all of which are published in the November 2009, 114 issue of Blood, are summarized below and are identified here by their abstract numbers.

Original languageEnglish (US)
Pages (from-to)277-280
Number of pages4
JournalAmerican Journal of Hematology
Issue number4
StatePublished - Apr 1 2010
Externally publishedYes


ASJC Scopus subject areas

  • Hematology

Cite this